This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.
Cyanocobalamin is used to treat vitamin B12 deficiency in people with pernicious anemia and other conditions.
The classification of Drugs for Cyanocobalamin includes Injection, Oral and Spray . The proportion of Injection in 2017 is about 68%, and the proportion of Oral in 2017 is about 32%.
The drugs for Cyanocobalamin is used to treat and prevent a lack of vitamin B12 that may be caused by any of the following: pernicious anemia (lack of a natural substance needed to absorb vitamin B12 from the intestine); certain diseases, infections, or medications that decrease the amount of vitamin B12 absorbed from food; or a vegan diet (strict vegetarian diet that does not allow any animal products, including dairy products and eggs).
Drugs for Cyanocobalamin is application in Hospital & Clinic and Pharmacy. The most of Oral is used in Pharmacy.
The global Vitamin B12 (Cobalamin, Cyanocobalamin) market is valued at 310 million US$ in 2018 and will reach 400 million US$ by the end of 2025, growing at a CAGR of 3.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vitamin B12 (Cobalamin, Cyanocobalamin) market based on company, product type, end user and key regions.
This report studies the global market size of Vitamin B12 (Cobalamin, Cyanocobalamin) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vitamin B12 (Cobalamin, Cyanocobalamin) in these regions.
This research report categorizes the global Vitamin B12 (Cobalamin, Cyanocobalamin) market by top players/brands, region, type and end user. This report also studies the global Vitamin B12 (Cobalamin, Cyanocobalamin) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Luitpold Pharmaceuticals (Daiichi Sankyo)
Market size by Product
Market size by End User
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Vitamin B12 (Cobalamin, Cyanocobalamin) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vitamin B12 (Cobalamin, Cyanocobalamin) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vitamin B12 (Cobalamin, Cyanocobalamin) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vitamin B12 (Cobalamin, Cyanocobalamin) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Vitamin B12 (Cobalamin, Cyanocobalamin) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vitamin B12 (Cobalamin, Cyanocobalamin) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.